高级检索

舒芬太尼诱发呛咳反应机制及预防用药的研究进展

Research progress of mechanism and preventive medication about sufentanil-induced cough response

  • 摘要: 舒芬太尼常用于抑制全麻诱导时气管插管引起的心血管反应,但在注射时可引起患者呛咳,剧烈呛咳可导致闭合空腔脏器压力骤增,尤其可增加颅高压及气胸等患者的麻醉诱导风险。注射不同剂量的舒芬太尼时,呛咳的发生率为28%~65%。多种药物及方法能不同程度地抑制全麻诱导中舒芬太尼所致的呛咳反应,但效能方面的比较文献相对较少。舒芬太尼诱导所用的浓度不同,预给药时机为2~15 min。本文对近年来不同药物抑制全麻诱导中舒芬太尼所致呛咳反应的文献进行总结,从舒芬太尼所致呛咳反应的机制、影响因素、预防给药方面作一综述。

     

    Abstract: Sufentanil is often used to inhibit the cardiovascular response caused by tracheal intubation during general anesthesia induction, but it can cause cough in patients during injection, and severe cough response can increase closed cavity organ pressure in patients, especially can increase the risk of anesthesia induction for patients with intracranial hypertension and pneumothorax. The incidence of cough varies from 28% to 65%, according to the difference of sufentanil dosage. A lot of drugs and methods can inhibit sufentanil-induced cough response in different degrees, however, the comparative literature on efficacy is relatively few. The dose of sufentanil is different, and the timing of pre-dosing varies from 2 to 15 minutes. This article reviews the preventive medication for sufentanil-induced cough response in papers in recent years, including the mechanism, the influential factors, preventive medication.

     

/

返回文章
返回